Skip to main content
Erschienen in: Rheumatology International 1/2017

30.08.2016 | Imaging

Evaluation of cardiovascular risk in stages of gout by a complex multimodal ultrasonography

verfasst von: Rada Gancheva, Atanas Kundurdjiev, Mariana Ivanova, Todor Kundurzhiev, Zlatimir Kolarov

Erschienen in: Rheumatology International | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

The aim of our work was to assess ultrasound features of cardiovascular (CV) risk in stages of gout. Cross-sectional complex multimodal ultrasound study of 169 age-matched patients, with similar distribution of arterial hypertension, diabetes mellitus, obesity and chronic renal failure, was divided into four groups: 41 with asymptomatic hyperuricemia, 52 gout without tophi, 42 gouty tophi and 34 controls with osteoarthritis. Parameters independently associated with CV risk were measured: renal resistive index (RRI), left ventricular mass index (LVMi), mitral annulus early diastolic velocity (e′), intima-media thickness (IMT) and common carotid artery resistive index (CCARI). Multivariate analyses were performed to evaluate the impact of gout stages and CV risk factors on ultrasound alterations. Gouty tophi increased the risk of having IMT >0.90 mm with an OR 11.51 (95 % CI 2.32–57.21, p = 0.003), gout without tophi raised the risk with an OR 6.25 (95 % CI 1.37–28.44, p = 0.018), while asymptomatic hyperuricemia had no effect on IMT. The category of CCARI >0.70 was influenced by tophi with an OR 11.18 (95 % CI 2.61–47.83, p = 0.001) and by arterial hypertension with an OR 3.22 (95 % CI 1.11–9.36, p = 0.032). Neither asymptomatic hyperuricemia nor gout without tophi modified the development of abnormally high CCARI. Gout stages had no impact on LVMi, e′ and RRI. Tophi are related to worsened ultrasonographic parameters evaluating target organs in gout, relative to earlier stages of the disease. They create a strong risk of carotid arteries’ changes even beyond arterial hypertension.
Literatur
1.
Zurück zum Zitat Garrod A (1848) Observations on certain pathological conditions of the blood and urine, in gout, rheumatism and Bright’s disease. Med Chir Trans 31:83–97CrossRefPubMedPubMedCentral Garrod A (1848) Observations on certain pathological conditions of the blood and urine, in gout, rheumatism and Bright’s disease. Med Chir Trans 31:83–97CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Tuttle KR, Short RA, Johnson RJ (2001) Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol 87(12):1411–1414CrossRefPubMed Tuttle KR, Short RA, Johnson RJ (2001) Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol 87(12):1411–1414CrossRefPubMed
4.
Zurück zum Zitat Culleton BF, Larson MG, Kannel WB, Levy D (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131(1):7–13CrossRefPubMed Culleton BF, Larson MG, Kannel WB, Levy D (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 131(1):7–13CrossRefPubMed
8.
Zurück zum Zitat Leyva F, Anker SD, Godsland IF, Teixeira M, Hellewell PG, Kox WJ, Poole-Wilson PA, Coats AJS (1998) Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J 19(12):1814–1822CrossRefPubMed Leyva F, Anker SD, Godsland IF, Teixeira M, Hellewell PG, Kox WJ, Poole-Wilson PA, Coats AJS (1998) Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J 19(12):1814–1822CrossRefPubMed
9.
Zurück zum Zitat Cippoli JA, Ferreira-Sae MC, Martins RP, Pio-Magalhães JA, Bellinazzi VR, Matos-Souza JR, Nadruz W (2012) Relationship between serum uric acid and internal carotid resistive index in hypertensive women: a cross-sectional study. BMC Cardiovasc Disord 12:52. doi:10.1186/1471-2261-12-52 CrossRef Cippoli JA, Ferreira-Sae MC, Martins RP, Pio-Magalhães JA, Bellinazzi VR, Matos-Souza JR, Nadruz W (2012) Relationship between serum uric acid and internal carotid resistive index in hypertensive women: a cross-sectional study. BMC Cardiovasc Disord 12:52. doi:10.​1186/​1471-2261-12-52 CrossRef
10.
Zurück zum Zitat Ward HJ (1998) Uric acid as an independent risk factor in the treatment of hypertension. Lancet 352(9129):670–671CrossRefPubMed Ward HJ (1998) Uric acid as an independent risk factor in the treatment of hypertension. Lancet 352(9129):670–671CrossRefPubMed
11.
Zurück zum Zitat Fukui M, Tanaka M, Shiraishi E, Harusato I, Hosoda H, Asano M, Kadono M, Hasegawa G, Yoshikawa T, Nakamura N (2008) Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus. Metabolism 57(5):625–629. doi:10.1016/j.metabol.2007.12.005 CrossRefPubMed Fukui M, Tanaka M, Shiraishi E, Harusato I, Hosoda H, Asano M, Kadono M, Hasegawa G, Yoshikawa T, Nakamura N (2008) Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus. Metabolism 57(5):625–629. doi:10.​1016/​j.​metabol.​2007.​12.​005 CrossRefPubMed
12.
Zurück zum Zitat Li Q, Yang Z, Lu B, Wen J, Ye Z, Chen L, He M, Tao X, Zhang W, Huang Y, Zhang Z, Qu S, Hu R (2011) Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol 10:72. doi:10.1186/1475-2840-10-72 CrossRefPubMedPubMedCentral Li Q, Yang Z, Lu B, Wen J, Ye Z, Chen L, He M, Tao X, Zhang W, Huang Y, Zhang Z, Qu S, Hu R (2011) Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol 10:72. doi:10.​1186/​1475-2840-10-72 CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Okura T, Higaki J, Kurata M, Irita J, Miyoshi K, Yamazaki T, Hayashi D, Kohro T, Nagai R (2009) Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: subanalysis of the Japanese Coronary Artery Disease (JACD) study. Circ J 73(5):885–891CrossRefPubMed Okura T, Higaki J, Kurata M, Irita J, Miyoshi K, Yamazaki T, Hayashi D, Kohro T, Nagai R (2009) Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: subanalysis of the Japanese Coronary Artery Disease (JACD) study. Circ J 73(5):885–891CrossRefPubMed
14.
Zurück zum Zitat Filippatos GS, Ahmed MI, Gladden JD, Mujib M, Aban IB, Love E, Sanders PW, Pitt B, Anker SD, Ahmed A (2011) Hyperuricemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data. Eur Heart J 32(6):712–720. doi:10.1093/eurheartj/ehq473 CrossRefPubMedPubMedCentral Filippatos GS, Ahmed MI, Gladden JD, Mujib M, Aban IB, Love E, Sanders PW, Pitt B, Anker SD, Ahmed A (2011) Hyperuricemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data. Eur Heart J 32(6):712–720. doi:10.​1093/​eurheartj/​ehq473 CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Abbott RD, Brand FN, Kannel WB, Castelli WP (1988) Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol 41(3):237–242CrossRefPubMed Abbott RD, Brand FN, Kannel WB, Castelli WP (1988) Gout and coronary heart disease: the Framingham Study. J Clin Epidemiol 41(3):237–242CrossRefPubMed
17.
Zurück zum Zitat Krishnan E, Baker JF, Furst DE, Schumacher HR (2006) Gout and the risk of acute myocardial infarction. Arthritis Rheum 54(8):2688–2696CrossRefPubMed Krishnan E, Baker JF, Furst DE, Schumacher HR (2006) Gout and the risk of acute myocardial infarction. Arthritis Rheum 54(8):2688–2696CrossRefPubMed
18.
Zurück zum Zitat Choi HK, Curhan G (2007) Independent impact of gout on mortality and risk for coronary heart disease. Circulation 116(8):894–900CrossRefPubMed Choi HK, Curhan G (2007) Independent impact of gout on mortality and risk for coronary heart disease. Circulation 116(8):894–900CrossRefPubMed
19.
Zurück zum Zitat van Durme C, van Echteld IA, Falzon L (2014) Cardiovascular risk factors and comorbidities in patients with hyperuricemia and/or gout: a systematic review of the literature. J Rheumatol Suppl 92:9–14. doi:10.3899/jrheum.140457 CrossRefPubMed van Durme C, van Echteld IA, Falzon L (2014) Cardiovascular risk factors and comorbidities in patients with hyperuricemia and/or gout: a systematic review of the literature. J Rheumatol Suppl 92:9–14. doi:10.​3899/​jrheum.​140457 CrossRefPubMed
20.
Zurück zum Zitat Pan KL, Lin JC, Lin CL, Chen MC, Chang PJ, Hsiao JF, Chang ST, Chung CM (2014) The effects of gout on left atrial volume remodeling: a prospective echocardiographic study. Rheumatology (Oxford) 53(5):867–874. doi:10.1093/rheumatology/ket444 CrossRef Pan KL, Lin JC, Lin CL, Chen MC, Chang PJ, Hsiao JF, Chang ST, Chung CM (2014) The effects of gout on left atrial volume remodeling: a prospective echocardiographic study. Rheumatology (Oxford) 53(5):867–874. doi:10.​1093/​rheumatology/​ket444 CrossRef
21.
Zurück zum Zitat Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yü TF (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20(3):895–900CrossRefPubMed Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yü TF (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20(3):895–900CrossRefPubMed
22.
Zurück zum Zitat National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification (2002) Am J Kidney Dis 39(2 Suppl 1):S1–S266 National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification (2002) Am J Kidney Dis 39(2 Suppl 1):S1–S266
23.
Zurück zum Zitat Heine GH, Gerhart MK, Ulrich C, Köhler H, Girndt M (2005) Renal Doppler resistance indices are associated with systemic atherosclerosis in kidney transplant recipients. Kidney Int 68(2):878–885CrossRefPubMed Heine GH, Gerhart MK, Ulrich C, Köhler H, Girndt M (2005) Renal Doppler resistance indices are associated with systemic atherosclerosis in kidney transplant recipients. Kidney Int 68(2):878–885CrossRefPubMed
24.
Zurück zum Zitat Tublin ME, Bude RO, Platt JF (2003) The resistive index in renal Doppler sonography: where do we stand? AJR Am J Roentgenol 180(4):885–892CrossRefPubMed Tublin ME, Bude RO, Platt JF (2003) The resistive index in renal Doppler sonography: where do we stand? AJR Am J Roentgenol 180(4):885–892CrossRefPubMed
25.
Zurück zum Zitat Viazzi F, Leoncini G, Derchi LE, Pontremoli R (2014) Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient. J Hypertens 32(1):149–153CrossRefPubMed Viazzi F, Leoncini G, Derchi LE, Pontremoli R (2014) Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient. J Hypertens 32(1):149–153CrossRefPubMed
26.
Zurück zum Zitat Lang RM, Beirig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18(12):1440–1463CrossRefPubMed Lang RM, Beirig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18(12):1440–1463CrossRefPubMed
27.
Zurück zum Zitat Nagueh SF (2008) Tissue Doppler imaging for the assessment of left ventricular diastolic function. J Cardiovasc Ultrasound 16(3):76–79CrossRef Nagueh SF (2008) Tissue Doppler imaging for the assessment of left ventricular diastolic function. J Cardiovasc Ultrasound 16(3):76–79CrossRef
28.
Zurück zum Zitat Ho CY, Solomon SD (2006) A clinician’s guide to tissue Doppler imaging. Circulation 113:396–398CrossRef Ho CY, Solomon SD (2006) A clinician’s guide to tissue Doppler imaging. Circulation 113:396–398CrossRef
29.
Zurück zum Zitat Amato M, Montorsi P, Ravani A, Oldani E, Galli S, Ravagnani PM, Tremoli E, Baldassarre D (2007) Carotid intima-media thickness by B-mode ultrasound as a surrogate of coronary atherosclerosis: correlation with quantitative coronary angiography and coronary intravascular ultrasound findings. Eur Heart J 28(17):2094–2101CrossRefPubMed Amato M, Montorsi P, Ravani A, Oldani E, Galli S, Ravagnani PM, Tremoli E, Baldassarre D (2007) Carotid intima-media thickness by B-mode ultrasound as a surrogate of coronary atherosclerosis: correlation with quantitative coronary angiography and coronary intravascular ultrasound findings. Eur Heart J 28(17):2094–2101CrossRefPubMed
30.
Zurück zum Zitat Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T et al (2013) ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31(7):1281–1357. doi:10.1097/01.hjh.0000431740.32696.cc CrossRefPubMed Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T et al (2013) ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31(7):1281–1357. doi:10.​1097/​01.​hjh.​0000431740.​32696.​cc CrossRefPubMed
31.
Zurück zum Zitat Staub D, Meyerhans A, Bundi B, Schmid HP, Frauchinger B (2006) Prediction of cardiovascular morbidity and mortality: comparison of the internal carotid artery resistive index with the common carotid artery intima-media thickness. Stroke 37(3):800–805CrossRefPubMed Staub D, Meyerhans A, Bundi B, Schmid HP, Frauchinger B (2006) Prediction of cardiovascular morbidity and mortality: comparison of the internal carotid artery resistive index with the common carotid artery intima-media thickness. Stroke 37(3):800–805CrossRefPubMed
32.
Zurück zum Zitat Frauchinger B, Schmid HP, Roedel C, Moosmann P, Staub D (2001) Comparison of carotid arterial resistive indices with intima-media thickness as sonographic markers of atherosclerosis. Stroke 32(4):836–841CrossRef Frauchinger B, Schmid HP, Roedel C, Moosmann P, Staub D (2001) Comparison of carotid arterial resistive indices with intima-media thickness as sonographic markers of atherosclerosis. Stroke 32(4):836–841CrossRef
34.
Zurück zum Zitat Sarnak MJ, Tighiouart H, Manjunath G, MacLeond B, Griffith J, Salem D, Levey AS (2002) Anemia as a risk factor for cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol 40(1):27–33CrossRefPubMed Sarnak MJ, Tighiouart H, Manjunath G, MacLeond B, Griffith J, Salem D, Levey AS (2002) Anemia as a risk factor for cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol 40(1):27–33CrossRefPubMed
35.
Zurück zum Zitat Dalbeth N, Pool B, Gamble GD, Smith T, Callon KE, McQueen FM, Cornish J (2010) Cellular characterization of the gouty tophus: a quantitative analysis. Arthritis Rheum 62(5):1549–1556. doi:10.1002/art.27356 CrossRefPubMed Dalbeth N, Pool B, Gamble GD, Smith T, Callon KE, McQueen FM, Cornish J (2010) Cellular characterization of the gouty tophus: a quantitative analysis. Arthritis Rheum 62(5):1549–1556. doi:10.​1002/​art.​27356 CrossRefPubMed
36.
Zurück zum Zitat Ridker PM (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107(3):363–369CrossRefPubMed Ridker PM (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107(3):363–369CrossRefPubMed
39.
Zurück zum Zitat Jialal I, Verma S, Devaraj S (2009) Inhibition of endothelial nitric oxide synthase by C-reactive protein: clinical relevance. Clin Chem 55(2):206–208CrossRefPubMed Jialal I, Verma S, Devaraj S (2009) Inhibition of endothelial nitric oxide synthase by C-reactive protein: clinical relevance. Clin Chem 55(2):206–208CrossRefPubMed
41.
Zurück zum Zitat Neogi T (2012) Asymptomatic hyperuricemia: cardiovascular and renal complications. In: Terkeltaub R (ed) Gout and other crystal arthropathies, 1st edn. Elsevier Saunders, Amsterdam, pp 226–238CrossRef Neogi T (2012) Asymptomatic hyperuricemia: cardiovascular and renal complications. In: Terkeltaub R (ed) Gout and other crystal arthropathies, 1st edn. Elsevier Saunders, Amsterdam, pp 226–238CrossRef
42.
Zurück zum Zitat Mitsuhashi H, Yatsuya H, Matsushita K, Zhang H, Otsuka R, Muramatsu T, Takefuji S, Hotta Y, Kondo T, Murohara T, Toyoshima H, Tamakoshi K (2009) Uric acid and left ventricular hypertrophy in Japanese men. Circ J 73(4):667–672CrossRefPubMed Mitsuhashi H, Yatsuya H, Matsushita K, Zhang H, Otsuka R, Muramatsu T, Takefuji S, Hotta Y, Kondo T, Murohara T, Toyoshima H, Tamakoshi K (2009) Uric acid and left ventricular hypertrophy in Japanese men. Circ J 73(4):667–672CrossRefPubMed
43.
Zurück zum Zitat Dannenberg AL, Levy D, Garrison RJ (1989) Impact of age on echocardiographic left ventricular mass in healthy population (the Framingham Study). Am J Cardiol 64(16):1066–1068CrossRefPubMed Dannenberg AL, Levy D, Garrison RJ (1989) Impact of age on echocardiographic left ventricular mass in healthy population (the Framingham Study). Am J Cardiol 64(16):1066–1068CrossRefPubMed
47.
Zurück zum Zitat Wang M, Yip GW, Wang AY, Zhang Y, Ho PY, Tse MK, Lam PK, Sanderson JE (2003) Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol 41(5):820–826CrossRefPubMed Wang M, Yip GW, Wang AY, Zhang Y, Ho PY, Tse MK, Lam PK, Sanderson JE (2003) Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol 41(5):820–826CrossRefPubMed
48.
Zurück zum Zitat Perez-Ruiz F, Martinez-Indart L, Carmona L, Herrero-Beites AM, Pijoan JI, Krishnan E (2014) Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout. Ann Rheum Dis 73(1):177–182. doi:10.1136/annrheumdis-2012-202421 CrossRefPubMed Perez-Ruiz F, Martinez-Indart L, Carmona L, Herrero-Beites AM, Pijoan JI, Krishnan E (2014) Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout. Ann Rheum Dis 73(1):177–182. doi:10.​1136/​annrheumdis-2012-202421 CrossRefPubMed
Metadaten
Titel
Evaluation of cardiovascular risk in stages of gout by a complex multimodal ultrasonography
verfasst von
Rada Gancheva
Atanas Kundurdjiev
Mariana Ivanova
Todor Kundurzhiev
Zlatimir Kolarov
Publikationsdatum
30.08.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 1/2017
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-016-3556-6

Weitere Artikel der Ausgabe 1/2017

Rheumatology International 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.